212 The same study tested cilostazol in a relatively small number of human patients with aSAH and observed a nonsignificant trend for decreased DCI, indicating a larger clinical trial may be worthwhile.
← all excerpts
Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review.
1
—
—